These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33988312)

  • 21. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment and post-treatment effects of alpha- versus beta-receptor blockers on left ventricular structure and function in essential hypertension.
    Schobel HP; Langenfeld M; Gatzka C; Schmieder RE
    Am Heart J; 1996 Nov; 132(5):1004-9. PubMed ID: 8892775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of left ventricular rotational mechanics in patients with systemic amyloidosis, systemic hypertension and normal left ventricular mass.
    Cappelli F; Porciani MC; Bergesio F; Perfetto F; De Antoniis F; Cania A; Tronconi F; Ricceri I; Padeletti L
    Clin Physiol Funct Imaging; 2011 Mar; 31(2):159-65. PubMed ID: 21310001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure.
    Marazzi G; Iellamo F; Volterrani M; Caminiti G; Madonna M; Arisi G; Massaro R; Righi D; Rosano GM
    Am J Cardiol; 2011 Jan; 107(2):215-9. PubMed ID: 21129714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic Strategy for Heart Failure with Reduced Ejection Fraction and Cardiac Amyloidosis.
    Imamura T; Izumida T; Nakamura M; Kinugawa K
    Int Heart J; 2022; 63(2):408-410. PubMed ID: 35354759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular inotropic reserve and right ventricular function predict increase of left ventricular ejection fraction after beta-blocker therapy in nonischemic cardiomyopathy.
    Ramahi TM; Longo MD; Cadariu AR; Rohlfs K; Carolan SA; Engle KM; Samady H; Wackers FJ
    J Am Coll Cardiol; 2001 Mar; 37(3):818-24. PubMed ID: 11693757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure.
    Gagliardi C; Perfetto F; Lorenzini M; Ferlini A; Salvi F; Milandri A; Quarta CC; Taborchi G; Bartolini S; Frusconi S; Martone R; Cinelli MM; Foffi S; Reggiani MLB; Fabbri G; Cataldo P; Cappelli F; Rapezzi C
    Eur J Heart Fail; 2018 Oct; 20(10):1417-1425. PubMed ID: 30070416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of guideline-recommended versus non-guideline-recommended β-blocker and Doppler echocardiographic parameters on 1-year mortality in Thai ischemic cardiomyopathy patients: A prospective multicenter registry.
    Wongpraparut N; Siwamogsatham S; Thongsri T; Ngamjanyaporn P; Phrommintikul A; Jirajarus K; Tangcharoen T; Bhumimuang K; Kaewsuwanna P; Krittayaphong R; Pongakasira R; White HD
    BMC Cardiovasc Disord; 2020 Jan; 20(1):8. PubMed ID: 31918676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low Utilization of Beta-Blockers Among Medicare Beneficiaries Hospitalized for Heart Failure With Reduced Ejection Fraction.
    Loop MS; van Dyke MK; Chen L; Safford MM; Kilgore ML; Brown TM; Durant RW; Levitan EB
    J Card Fail; 2019 May; 25(5):343-351. PubMed ID: 30339796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale and Design of the Multicenter Trial on Japan Working Group on the Effects of Angiotensin Receptor Blockers Selection (Azilsartan vs. Candesartan) on Diastolic Function in the Patients Suffering from Heart Failure with Preserved Ejection Fraction: J-TASTE Trial.
    Takahama H; Asakura M; Abe Y; Ajioka M; Aonuma K; Anzai T; Hayashi T; Hiramitsu S; Kawai H; Kioka H; Kimura K; Lim YJ; Matsuoka K; Motoki H; Nagata Y; Nakamura S; Ohte N; Ozaki Y; Sasaoka T; Tamaki S; Hamasaki T; Kitakaze M;
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):381-388. PubMed ID: 29974299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. β-Blockers and ivabradine differentially affect cardiopulmonary function and left ventricular filling index.
    Fischer-Rasokat U; Honold J; Lochmann D; Wolter S; Liebetrau C; Fichtlscherer S; Möllmann H; Spyridopoulos I; Hamm CW
    Clin Res Cardiol; 2016 Jun; 105(6):527-34. PubMed ID: 26687495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of β-blocker therapy for long-term outcomes in patients with low ejection fraction after cardiac surgery.
    Fan FD; Zhang HT; Pan T; Tang XL; Wang DJ
    BMC Cardiovasc Disord; 2020 Aug; 20(1):379. PubMed ID: 32819270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Heart failure with preserved left ventricular function: clinical, echocardiographic, and clinical course features. Prognostic factors].
    Bounhoure JP; Massabuau P; Galinier M; Jordan C; Laurent JP; Marco J
    Bull Acad Natl Med; 2002; 186(6):1003-13; discussion 1013-4. PubMed ID: 12587339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial fibrillation ablation in patients with transthyretin cardiac amyloidosis.
    Donnellan E; Wazni O; Kanj M; Elshazly MB; Hussein A; Baranowski B; Hanna M; Patel D; Trulock K; Martyn M; Menon V; Saliba W; Jaber WA
    Europace; 2020 Feb; 22(2):259-264. PubMed ID: 32031230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
    Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
    JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrial Fibrillation in Transthyretin Cardiac Amyloidosis: Predictors, Prevalence, and Efficacy of Rhythm Control Strategies.
    Donnellan E; Wazni OM; Hanna M; Elshazly MB; Puri R; Saliba W; Kanj M; Vakamudi S; Patel DR; Baranowski B; Cantillon D; Dresing T; Jaber WA
    JACC Clin Electrophysiol; 2020 Sep; 6(9):1118-1127. PubMed ID: 32972546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between β-Blocker Use and Mortality/Morbidity in Patients With Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction and Advanced Chronic Kidney Disease.
    Fu EL; Uijl A; Dekker FW; Lund LH; Savarese G; Carrero JJ
    Circ Heart Fail; 2020 Nov; 13(11):e007180. PubMed ID: 33070637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice.
    Fishkind D; Paris BE; Aronow WS
    J Am Geriatr Soc; 1997 Jul; 45(7):809-12. PubMed ID: 9215330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Frequency of use and Indications for Beta-Blockers in Heart Failure with Preserved Ejection Fraction].
    Kokhan EV; Kiyakbaev GK; Kobalava ZD
    Kardiologiia; 2020 Jul; 60(6):30-40. PubMed ID: 32720613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of right ventricular systolic function in cardiac amyloidosis.
    Bodez D; Ternacle J; Guellich A; Galat A; Lim P; Radu C; Guendouz S; Bergoend E; Couetil JP; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Deux JF; Mohty D; Damy T
    Amyloid; 2016 Sep; 23(3):158-167. PubMed ID: 27348696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.